AskBio Presents Preliminary Data from Phase 1 Trial of Gene Therapy for Congestive Heart Failure (CHF) at the 2023 American Heart Association Scientific Sessions ...Middle East

First-in-human trial of AB-1002 designed to establish safety and preliminary efficacy in patients with NYHA Class III Heart Failure Heart failure is a leading cause of morbidity and mortality worldwide despite available therapies, and quality of life is poor1 It is estimated 26 million...

Hence then, the article about askbio presents preliminary data from phase 1 trial of gene therapy for congestive heart failure chf at the 2023 american heart association scientific sessions was published today ( Sunday 12/11/2023 - 05:56 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AskBio Presents Preliminary Data from Phase 1 Trial of Gene Therapy for Congestive Heart Failure (CHF) at the 2023 American Heart Association Scientific Sessions )

Also on site :

• Despite having a $25 million net worth, Hilary Duff thinks saying yes too much to opportunities actually hurt her career
• Your Complete Guide to the 2026 FIFA World Cup
• Psychologist Says if You Have To Listen To Something While Walking, You Likely Have These 7 Traits